PNRG INVESTOR NOTICE: Kaskela Law Firm Announces Investigation of PrimeEnergy Resources Corporation (PNRG) and Encourages PNRG Shareholders with Losses to Contact the Firm GlobeNewswire January 05, 2026 PHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating PrimeEnergy Resources Corporation (NASDAQ: PNRG) (“PrimeEnergy”) on behalf of the company's shareholders to […]

NUTANIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutanix, Inc. on Behalf of Nutanix Stockholders and Encourages Investors to Contact the Firm GlobeNewswire January 05, 2026 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutanix (NTNX) To Contact Him Directly To Discuss Their Options If you purchased

NEW YORK, NY / ACCESS Newswire / January 5, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ:CORT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Corcept and certain of its officers and/or directors

Toronto, Ontario–(Newsfile Corp. – January 5, 2026) – Atrium Mortgage Investment Corporation (TSX: AI) (“Atrium”) is pleased to announce its regular monthly dividend policy for 2026. The annual dividend rate remains unchanged at $0.93 per common share, payable in monthly installments of $0.0775 per common share. Each dividend must be approved by Atrium’s board of directors. Atrium’s

(NYSE:WSR), HOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) — James C. Mastandrea, a significant shareholder of Whitestone REIT (“Whitestone” or the “Company”) (NYSE: WSR) since its IPO in 2010, today announced that he intends to nominate a slate of new, highly qualified independent trustees experienced in commercial real estate and public and private capital markets to

(NASDAQ:IART), PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 05, 2026 PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the

James C. Mastandrea Announces Proposal to Replace Whitestone REIT Board After Years of Underperformance GlobeNewswire January 05, 2026 HOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) — James C. Mastandrea, a significant shareholder of Whitestone REIT (“Whitestone” or the “Company”) (NYSE: WSR) since its IPO in 2010, today announced that he intends to nominate a slate of

(TSX:PD),(NYSE:PDS), CALGARY, Alberta, Jan. 05, 2026 (GLOBE NEWSWIRE) — Precision Drilling Corporation (Precision) intends to release its 2025 fourth quarter and year-end results after the market closes on Wednesday, February 11, 2026, and has scheduled a conference call to begin at 11:00 a.m. MT (1:00 p.m. ET) on the next day, Thursday, February 12, 2026.

(CNSX:DRUG.CN),(CNSX:DRUG),(NASDAQ:DRUG), – Conference Call and Live Webcast at 8AM ET – NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (Nasdaq: DRUG) (“Bright Minds” or the “Company”), a clinical-stage biotechnology company focused on developing highly selective 5-HT receptor agonists for neurological and psychiatric disorders, today announced that it will host